ACADIA Pharmaceuticals Inc (ACAD)
Operating return on assets (Operating ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 230,794 | -73,379 | -223,596 | -170,439 | -286,586 |
| Total assets | US$ in thousands | 1,187,760 | 748,956 | 587,812 | 700,122 | 782,616 |
| Operating ROA | 19.43% | -9.80% | -38.04% | -24.34% | -36.62% |
December 31, 2024 calculation
Operating ROA = Operating income ÷ Total assets
= $230,794K ÷ $1,187,760K
= 19.43%
ACADIA Pharmaceuticals Inc's operating return on assets (Operating ROA) has fluctuated over the years based on the provided data.
- As of December 31, 2020, the operating ROA was -36.62%, indicating that the company generated a negative return on its assets from its core operations.
- By December 31, 2021, there was a slight improvement in the operating ROA to -24.34%, although it still remained negative.
- However, by December 31, 2022, the operating ROA worsened to -38.04%, suggesting a decline in the company's ability to generate profits from its assets.
- The trend changed positively by December 31, 2023, with the operating ROA improving to -9.80%, moving towards a positive territory.
- Finally, as of December 31, 2024, the operating ROA significantly improved to 19.43%, indicating that the company's core operations were generating a positive return on its assets.
The varying levels of operating ROA over the years indicate fluctuations in the company's operational efficiency and profitability. It is essential for investors and stakeholders to monitor these changes to assess the company's performance and potential for future growth.
Peer comparison
Dec 31, 2024